Total Hip and Knee Replacements Market Size to Hit USD 30.03 Billion by 2030 at 4.80% CAGR – Report by Market Research Future (MRFR)
July 17, 2023 06:40 ET
|
Market Research Future
New York, USA, July 17, 2023 (GLOBE NEWSWIRE) -- Total Hip and Knee Replacements Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Total Hip and...
Global Knee Replacement Devices Market Size & Analysis
March 20, 2023 03:49 ET
|
Global Market Estimates
Brooklyn, New York, March 20, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Knee Replacement Devices Market is expected to grow...
Joint Pain Injections Market to hit USD 9.5 Billion by 2032, says Global Market Insights Inc.
November 28, 2022 05:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The joint pain injections market value is set to reach USD 9.5 billion by 2032, as per a recent research report announced by Global Market...
Global Bone Replacement Market Anticipated to Garner $27,643.10 Million, Growing with 7.00% CAGR in the 2021–2028 Timeframe [180-Pages] | Released by Research Dive
November 09, 2022 09:04 ET
|
Research Dive
New York, USA, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global bone replacement market. According to the report, the global market is projected to surpass...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMPE
August 19, 2022 10:51 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Global Bone Replacement Market Expected to Generate a Revenue of $27,643.10 million by 2028, Growing at a CAGR of 7.00% from 2021-2028 | Confirmed [180-Pages] by Research Dive
April 20, 2022 09:00 ET
|
Research Dive
New York, USA, April 20, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global bone replacement market is projected to garner a revenue of $27,643.10 million by...
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
August 30, 2021 01:00 ET
|
Bone Therapeutics SA
REGULATED INFORMATION No statistically significant difference in knee pain reduction between JTA-004, placebo and active comparator, 3 months after treatment; favorable JTA-004 safety profile...
Bone Therapeutics annonce les résultats principaux de l'étude de Phase III évaluant son viscosupplément amélioré, le JTA-004, dans l'arthrose du genou
August 30, 2021 01:00 ET
|
Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Aucune différence statistiquement significative n’a été observée dans la réduction de la douleur du genou entre JTA-004, le placebo et le comparateur actif 3 mois après le...
Bone Therapeutics provides update on the progress of clinical studies
July 19, 2021 01:00 ET
|
Bone Therapeutics SA
REGULATED INFORMATION JTA-004 Phase III top-line results planned first half September ALLOB Phase IIb currently on track but recruitment slow due to COVID-19 pandemic Gosselies,...
Bone Therapeutics fait le point sur l’avancement de ses études cliniques
July 19, 2021 01:00 ET
|
Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Les premiers résultats de la phase III évaluant JTA-004 sont prévus pour la première moitié de septembre La phase IIb évaluant ALLOB est en cours malgré un...